Familial antiphospholipid antibodies and acquired circulating anticoagulants

I. ElHajj, I. Uthman, A. Chahel, F. Khoury, T. Arayssi, Ali Taher

Research output: Contribution to journalArticle

5 Citations (Scopus)


Familial clustering of elevated antiphospholipid antibody levels has been described, but the reports are heterogeneous with regard to the characterization of the antiphospholipid syndrome (APS), coexisting autoimmune diseases and clinical implications. We report a familial occurrence of APS in two patients, in the presence of SLE in the mother and absence of autoimmune diseases in the daughter along with acquired circulating inhibitors in both cases: platelet inhibitor and factor IX inhibitor, respectively.

Original languageEnglish
Pages (from-to)812-814
Number of pages3
Issue number10
Publication statusPublished - 16 Nov 2004



  • Factor IX inhibitor
  • Familial antiphospholipid syndrome
  • Platelet inhibitor
  • Prolonged bleeding time

ASJC Scopus subject areas

  • Rheumatology

Cite this